FRILAB Laboratories, based in Switzerland, develop and market a broad range of pharmaceutical products, medical devices and dietary supplements dedicated to medical prescription, family health, nutrition, as well as a wide variety of hospital specialties.
Our expertise covers both products developed internally by our teams and those acquired from international partners or entrusted to FRILAB under a fully integrated management framework.
Our model is founded on a core requirement: offering reliable, accessible therapeutic solutions that comply with European quality standards, in order to respond effectively to market realities.
Although FRILAB Laboratories are historically established in Switzerland, our growth is driven by a targeted international strategy. Our activities are focused on regions where we work in close collaboration with local representatives who possess an indepth understanding of the needs of healthcare professionals and patients.
Among these regions, the African continent holds a central place in our mission and our history. Thanks to a longstanding presence and sustainable partnerships with both public and private stakeholders, our development in these markets reflects the strong reputation and trust that the continent has placed in us.
Our local approach, combined with Swiss expertise, enables us to provide solutions adapted to the healthcare systems and socioeconomic conditions of the continent, while contributing to improved access to essential care.
